AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 58 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -80.0% | 29,526 | -6.3% | 0.00% | – |
| Q2 2022 | $5,000 | -64.3% | 31,526 | 0.0% | 0.00% | – |
| Q1 2022 | $14,000 | -26.3% | 31,526 | -6.2% | 0.00% | – |
| Q4 2021 | $19,000 | -67.8% | 33,626 | -5.6% | 0.00% | – |
| Q3 2021 | $59,000 | 0.0% | 35,626 | 0.0% | 0.00% | – |
| Q2 2021 | $59,000 | 0.0% | 35,626 | +1.7% | 0.00% | – |
| Q1 2021 | $59,000 | +7.3% | 35,044 | 0.0% | 0.00% | – |
| Q4 2020 | $55,000 | +77.4% | 35,044 | +6.1% | 0.00% | – |
| Q3 2020 | $31,000 | +138.5% | 33,044 | +57.4% | 0.00% | – |
| Q2 2020 | $13,000 | +62.5% | 20,996 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | +14.3% | 20,996 | +69.3% | 0.00% | – |
| Q4 2019 | $7,000 | 0.0% | 12,400 | -21.2% | 0.00% | – |
| Q3 2019 | $7,000 | +16.7% | 15,734 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | +20.0% | 15,734 | +52.3% | 0.00% | – |
| Q1 2019 | $5,000 | -96.6% | 10,334 | -71.7% | 0.00% | -100.0% |
| Q4 2017 | $149,000 | – | 36,546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shilanski & Associates, Inc. | 937,237 | $57,000 | 0.02% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $57,000 | 0.02% |
| CVA Family Office, LLC | 1,137,920 | $69,000 | 0.02% |
| Cypress Capital Management LLC (WY) | 140,925 | $9,000 | 0.01% |
| Helen Stephens Group, LLC | 117,222 | $7,000 | 0.01% |
| COURIER CAPITAL LLC | 540,056 | $33,000 | 0.00% |
| NORTHCAPE WEALTH MANAGEMENT, LLC | 98,000 | $6,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 10,000 | $1,000 | 0.00% |
| Western Wealth Management, LLC | 352,950 | $11,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 606,800 | $37,000 | 0.00% |